Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-08-22
2010-02-09
Gambel, Phillip (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007200, C435S007210, C435S375000, C435S377000
Reexamination Certificate
active
07659084
ABSTRACT:
What is suggested herein is the use of CD154 for the detection and/or isolation of antigen-specific T lymphocytes and a method for the detection and/or isolation of antigen-specific T lymphocytes, wherein the suspension is contacted with a CD40/CD154 system inhibitor, intra- or extracellular determination of CD154 is effected, and the cells having CD154 are detected and/or isolated.
REFERENCES:
patent: 6576428 (2003-06-01), Assenmacher et al.
patent: 2003/0012781 (2003-01-01), Darrell et al.
patent: WO 9958977 (1999-11-01), None
Batataglia et al., Am. J. Gastroenterology 94: 3279-3284, 1999.
XP002937171—Berner et al. ; “Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis”; Nov. 1999; pp. 190-195.
XP001053568—Schonbeck et al.; “Molecules in focus”; The International Journal of Biochemistry & Cell Biology, vol. 32 , 2000; pp. 687-693.
Fisher et al.; “Immunomagnetic separation reagents as markers in electron microscopy”; Journal of Immunological Methods; vol. 262, 2002; pp. 95-101.
XP000887155— Valmori et al.; “An Antigen-targeted Approach to Adoptive Transfer Therapy of Cancer”; Cancer Research, vol. 59, May 1999; pp. 2167-2173.
XP002220000; Lee et al.; “The biological outcome of CD40 signaling in B lymphocytes is dependent on the duration of CD154 expression on T cells: Reciprocal regulation by 1L-4 and IL-12”; FASEB Journal; Mar., 2002; 1 p.
Berner et al: “Increased Expression of CD40 Ligand (CD154) on CD4+ T Cells as a Marker of Disease Activity in Rheumatoid Arthritis” Annals of the Rheumatic Diseases, British Medical Association, London, GB, vol. 59, 2000, pp. 190-195.
Schoenbeck U et al: “CD154 (CD40 Ligand)” International Journal of Biochemistry and Cell Biology, Exeter, GB, vol. 32, No. 7, Jul. 2000, pp. 687-693.
Fisher P J et al. “Immunomagnetic Separation Reagents as Markers in Electron Microscopy” Journal of Immunological Methods, Elsevier, Amsterdam, NL, vol. 262, No. 1-2, Apr. 1, 2002, pp. 95-101.
Database Biosis ′Online! Biosciences Inforamtion Service, Philadelphia, PA, US; Mar. 20, 2002, Lee Byung O et al.: “The Biological Outcome of CD40 Signaling in B Lymphocytes is Dependent on the Duration of CD154 Expression on T Cells: Reciprocal Regulation by IL-4 and IL-12.”
FASEB Journal, vol. 16, No. 4, Mar. 20, 2002, p. A350, Annual Meeting of the Professional Research Scientists on Experimental Biology; New Orleans, Louisiana, USA; Apr. 20-24, Mar. 20, 2002.
Valmori D et al: “Antigen-Targeted Approach to Adoptive Transfer Therapy of Cancer” Cancer Research, American Association for Cancer Research, Baltimore, MD, vol. 59, No. 9, 1999, pp. 2167-2173.
Frentsch Marco
Rothe Martin
Thiel Andreas
Gambel Phillip
Millen White Zelano & Branigan P.C.
Miltenyi Biotec GmbH
LandOfFree
Methods for detecting and isolating antigen-specific T... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting and isolating antigen-specific T..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting and isolating antigen-specific T... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234015